换一批
换一批Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.
作者：
Michael C J,Quinn [1]
;
Karen,McCue [1]
;
Wei,Shi [1]
;
Sharon E,Johnatty [1]
;
Jonathan,Beesley [1]
;
Andrew,Civitarese [1]
;
Tracy A,O'Mara [1]
;
Dylan M,Glubb [1]
;
Jonathan P,Tyrer [2]
;
Sebastian M,Armasu [3]
;
Jue-Sheng,Ong [1]
;
Puya,Gharahkhani [1]
;
Yi,Lu [1]
;
Bo,Gao [4]
;
Ann-Marie,Patch [1]
;
Peter A,Fasching [5]
;
Matthias W,Beckmann [6]
;
Diether,Lambrechts [7]
;
Ignace,Vergote [8]
;
Digna R,Velez Edwards [9]
;
Alicia,Beeghly-Fadiel [10]
;
Javier,Benitez [11]
;
Maria J,Garcia [12]
;
Marc T,Goodman [13]
;
Thilo,Dörk [14]
;
Matthias,Dürst [15]
;
Francesmary,Modugno [16]
;
Kirsten,Moysich [17]
;
Andreas,du Bois [18]
;
Jacobus,Pfisterer [19]
;
Klaus,Bauman [20]
;
Beth Y,Karlan [20]
;
Jenny,Lester [21]
;
Julie M,Cunningham [3]
;
Melissa C,Larson [3]
;
Bryan M,McCauley [22]
;
Susanne K,Kjaer [23]
;
Allan,Jensen [24]
;
Claus K,Hogdall [25]
;
Estrid,Hogdall [26]
;
Joellen M,Schildkraut [27]
;
Marjorie J,Riggan [27]
;
Andrew,Berchuck [28]
;
Daniel W,Cramer [29]
;
Kathryn L,Terry [30]
;
Line,Bjorge [31]
;
Penelope M,Webb [32]
;
Michael,Friedlander [32]
;
Tanja,Pejovic [33]
;
Melissa,Moffitt [34]
;
Rosalind,Glasspool [34]
;
Taymaa,May [35]
;
Gabrielle E V,Ene [36]
;
David G,Huntsman [37]
;
Michelle,Woo [38]
;
Michael E,Carney [39]
;
Samantha,Hinsley [40]
;
Florian,Heitz [41]
;
Sian,Fereday [1]
;
Catherine J,Kennedy [3]
;
Stacey L,Edwards [42]
;
Stacey J,Winham [3]
;
Anna,deFazio [1]
;
Paul D P,Pharoah [43]
;
Ellen L,Goode ;
Stuart,MacGregor ;
Georgia,Chenevix-Trench ;
AGO Study Group ;
OPAL Study Group ;
for Australian Ovarian Cancer Study Group
作者单位：
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[1]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
[2]
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
[3]
Crown Princess Mary Cancer Care Centre, Westmead Hospital, Sydney, New South Wales, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
[4]
Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California.;Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
[5]
Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
[6]
VIB Center for Cancer Biology, VIB, Leuven, Belgium.;Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
[7]
Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
[8]
Department of Obstetrics and Gynecology, Vanderbilt Epidemiology Center, Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, Tennessee.
[9]
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
[10]
Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
[11]
Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.;Computational Oncology Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
[12]
Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.;Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
[13]
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
[14]
Department of Gynecology, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
[15]
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.;Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.;Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.
[16]
Division of Cancer Prevention and Population Sciences, Cancer Pathology & Prevention, Roswell Park Cancer Institute, Buffalo, New York.
[17]
Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.;Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
[18]
Gynecologic Oncology Center, Kiel, Germany.
[19]
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
[20]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
[21]
Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.;Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
[22]
Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
[23]
Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
[24]
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.;Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
[25]
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
[26]
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
[27]
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
[28]
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.;Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
[29]
Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.;Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
[30]
Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
[31]
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon.;Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
[32]
Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom.
[33]
Division of Gynecologic Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
[34]
British Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver General Hospital, BC Cancer Agency and University of British Columbia, British Columbia, Canada.;Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.;Department of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada.;Department of Molecular Oncology, The University of British Columbia, Vancouver, British Columbia, Canada.
[35]
British Columbia's Ovarian Cancer Research (OVCARE) Program, Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
[36]
Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
[37]
Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
[38]
Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.;Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.;Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
[39]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[40]
Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
[41]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.;Strangeways Research Laboratory, Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Worts Causeway, Cambridge, United Kingdom.
[42]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. georgia.trench@qimrberghofer.edu.au.
[43]
主题词
女(雌)性(Female);基因敲除技术(Gene Knockout Techniques);全基因组关联研究(Genome-Wide Association Study);人类(Humans);细胞内信号肽和蛋白质类(Intracellular Signaling Peptides and Proteins);卵巢肿瘤(Ovarian Neoplasms);多态性, 单核苷酸(Polymorphism, Single Nucleotide)
DOI
10.1158/1055-9965.EPI-20-1817
PMID
34162658
发布时间
2024-09-06
- 浏览4
Cancer epidemiology, biomarkers & prevention
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
